Zantac Lawsuits Related to Stomach and Bladder Cancer
Earlier this year, the Food and Drug Administration (FDA) announced that they are opening an investigation into the risks of cancer among users of Zantac 150 tablets. Recent testing revealed that the 150 tablets contain a carcinogenic chemical that is up to 3,000 times greater than the Food and Drug Administration’s daily intake limit. This carcinogenic found in Zantac is known as N-nitrosodimethylamine (NDMA).
What is Zantac?
Zantac is an extremely popular antacid medication that’s been for sale since the early 1980s. It’s chemically known as ranitidine hydrochloride and is available over the counter and by prescription.
Zantac is used by many people for acid reflux, heartburn, and other gastrointestinal, throat, and stomach issues. There are also people who use Zantac for allergies as a supplement in their treatment plans.
The dosage of Zantac can vary to between 75 and 150 mg tablets, and in some cases, 300 mg dosages.
What Does the NDMA in Zantac Do?
NDMA was first discovered in the process of manufacturing rocket fuel. Additionally, for over 40 years, various studies have shown the NDMA is dangerous. Today, NDMA only has one purpose: to induce cancer in laboratory experiments.
According to allegations brought forth in various Zantac lawsuits, the manufacturers of Zantac didn’t disclose to the public that Zantac, when ingested, produces very high quantities of NDMA.
Can Zantac Cause Cancer?
Zantac and its generic active ingredient, ranitidine hcl, when ingested, metabolizes into NDMA which is a chemical that the Food and Drug Administration, the U.S. Environmental Protection Agency, and the World Health Organization all classify as a carcinogen.
In the last 40 years, numerous studies have helped make a case that Zantac causes cancer. Some of the cancers that have been associated with Zantac include:
- Bladder Cancer
- Colon and Rectal Cancer
- Esophageal Cancer
- Intestinal Cancer
- Kidney Cancer
- Lung Cancer
- Liver Cancer
- Pancreatic Cancer
- Prostate Cancer
- Ovarian Cancer
- Testicular Cancer
- Thyroid Cancer
- Stomach Cancer
- Uterine Cancer
What Are the Different Brands of Zantac?
Users of Zantac have reported side effects that include abdominal discomfort, headaches, vomiting, and nausea. An online pharmacy company conducted a Food and Drug Administration-approved test of Zantac and found more than 3,000,000 ng (nanograms) of NDMA in Zantac 150mg tablet, a dosage that a lot of people take every single day in the United States. The Food and Drug Administration allows 96 ng of NDMA though the U.S. Agency for Toxic Substances and Disease Registry says this limit may be too high. Some of the most common brands of Zantac and generic rantidine include:
What Do The Zantac Lawsuits Allege?
An online pharmacy company conducted a Food and Drug Administration-approved test of Zantac and found more than 3,000,000 ng (nanograms) of NDMA in Zantac 150mg tablet, a dosage that a lot of people take every single day in the United States. The Food and Drug Administration allows 96 ng of NDMA through the U.S. Agency for Toxic Substances and Disease Registry says this limit may be too high.
According to Zantac lawsuits, if you take a daily maintenance Zantac dosage of 150 mg you are being exposed to 889,000,000 ng. of NDMA a year.
The lawsuits also allege that the manufacturers of Zantac knew or had a reason to know that their product, Zantac, exposes the public to unsafe levels of the cancer-causing chemical NDMA.
According to the lawsuits against Zantac, the manufacturers deliberately refused to test their Zantac products because they knew that the chemical NDMA posed significant health risks to the public.
What About The Class Action Zantac Lawsuits?
- The people who bought Zantac who do not have a claim for cancer could be eligible to join a class-action lawsuit to hold Sanofi and Boehringer Ingelheim accountable for making alleged misleading and/or false statements about Zantac.
- The manufacturers of Zantac marketed their product as being safe to treat acid reflux, heartburn, and various other issues.
